期刊文献+

乳腺癌组织中CD44v6和MMP-2的表达及其与淋巴结转移的关系 被引量:7

Relationship between the expression of CD44v6 and MMP-2 in breast carcinoma and lymph node metastasis
下载PDF
导出
摘要 目的:检测CD44v6、MMP-2在乳腺浸润性导管癌中的表达情况,探讨它们与淋巴结转移的关系。方法:采用免疫组化SP法检测100例乳腺浸润性导管癌中CD44v6、MMP-2的表达情况。结果:CD44v6蛋白在正常乳腺组织及乳腺浸润性导管癌中的阳性表达率分别为12.5%(5/40)、87%(87/100),CD44v6在淋巴结转移组中的阳性表达率(56/60)明显高于无淋巴结转移组(P<0.05)。MMP-2蛋白在正常乳腺组织及乳腺浸润性导管癌中的阳性表达率分别为0(0/40)、94%(94/100),MMP-2在淋巴结转移组中的阳性表达率(59/60)明显高于无淋巴结转移组(P<0.05)。结论:CD44v6、MMP-2蛋白在乳腺浸润性导管癌组织高表达,且均与淋巴结转移有关(P<0.05),联合检测CD44v6与MMP-2有助于综合判断乳腺浸润性导管癌的恶性程度和转移潜能。 Objective: To detect the expression of CD44v6 and MMP -2 in infiltrating ductal carcinoma, and explore their relationship with lymph node metastasis. Methods: The expression of CD44v6 and MMP -2 was studied in 100 cases of infiltrating ductal carcinoma by SP immunohistoehemistry. Results: The positive expression of CD44v6 protein in normal breast tissue and infiltrating ductal carcinoma was 12.5% (5/40) ,87% (87/100) respectively,and the positive rate of CD44v6 in patients with lymph node metastasis(56/60) significantly higher than those without lymph node metastasis( P 〈 0.05 ). The positive expression of MMP - 2 protein in normal breast tissue and infiltrating ductal carcinoma was 0(0/40) ,94% (94/100) respectively, and the positive rate of MMP -2 in patients with lymph node metastasis (59/60) significantly higher than those without lymph node metastasis (P 〈 0.05 ). Conclusion: CDd4v6 and MMP -2 protein are highly expressed in infiltrating ductal carcinoma and are all related with lymph node metastasis ( P 〈 0.05 ), combined detection of CD44v6 and MMP - 2 is useful to estimation of infiltrating ductal carcinoma malignancy and metastatic potential.
出处 《现代肿瘤医学》 CAS 2011年第2期272-273,共2页 Journal of Modern Oncology
基金 邯郸市科技局重点资助项目(编号:0923108059)
关键词 浸润性导管癌 CD44V6 MMP-2 转移 infiltrating ductal carcinoma CD44v6 MMP - 2 metastasis
  • 相关文献

参考文献6

  • 1Heider KH, Kuthan H, Stehle G, et al. CD44v6 : a target for anti- body - based cancer therapy. [ J ] Cancer Iramunol Immunother, 2004,53(7) :567 -579.
  • 2Heider KH, Kut han H, Stehle G, et al. CD44v6 : a target for antibody - based cancer therapy [ J ]. Cancer Immunol Immunother, 2004,53(7) :567 -579.
  • 3杨振林,曹明智,王荣华,吕增华.CD_(44v6)在乳腺癌中的表达及其临床意义[J].肿瘤研究与临床,2002,14(4):239-241. 被引量:4
  • 4赵亮,张玉宝,张殿忠.乳腺癌原发灶与转移灶CD44v6表达的对比研究[J].中国肿瘤临床,2004,31(7):410-411. 被引量:9
  • 5Nakopoulou L, Tsirmpa I, Alexandrou P, et al. MMP - 2 protein in invasive breast cancer and the impact of MMP - 2/TIMP - 2 phenotype on overall survival [J]. Breast Cancer Res Treat,2003, 77(2) :145 - 155.
  • 6Jones JL, Glynn P, WAlker RA. Expression of MMP - 2 and MMP -9 their inhibitors, and the activator MTI - MMP in primary breast carcinomas [ J]. J Pathol, 1999,189 (2) : 161 - 168.

二级参考文献11

  • 1刘复生,李晓.乳腺癌的组织学分级与预后[J].中华病理学杂志,1993,22(1):36-37. 被引量:28
  • 2Saito H, Tsujitanis, Katanok, et al. Serum concentration of CD44variant 6 and is relation to prognosis in patients with gastric carcinoma [J]. Cancer, 1998, 83(6):1094-1101
  • 3Yamamichi K, Vehara Y, Kitanura N, et al. Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer[J]. IntJ Cancer, 1998, 79(3):256-262
  • 4Gunthert U, Hofmann M, Rudy W, et al. A new variant of glucoprotein CD44 confers metastatic potential to rat carcinoma cell [J]. Cell, 1991, 65(1): 13-24
  • 5Coppola D, Hyacinthe M, Fu L, et al. CD44v6 expression in human colorectal carcinoma [J]. Hum Pathol, 1998, 29 (6): 627-635
  • 6Ladeda V, Aguirre U, Ghiso JA, et al. Function and expression of CD44 during spreading, and invasion of murine carcinoma cells [J]. Exp Cell Res, 1998, 242(2): 515-527
  • 7Goodison S, Tarin D. Current status of CD44 variant isoforms as cancer diagnostic markers[J]. Histopathology, 1998, 32(1): 1-9
  • 8ReederJA, Gotley DC, Walsh MD, et al. Expression of antisense CD44 variant 6 inhibits colorectal tumor growth in a wound environment[J]. Cancer Res, 1998, 58(16): 3719-3726
  • 9李祖国,丁彦青,邓永键,朱梅刚.CD_(44V6)在不同转移能力人大肠癌细胞系中的表达[J].临床与实验病理学杂志,1998,14(3):216-218. 被引量:14
  • 10张树华.关于乳腺癌病理学分型的建议[J].临床与实验病理学杂志,1999,15(2):168-169. 被引量:3

共引文献10

同被引文献58

  • 1申哲洙,顾晋,赵威,张志谦.尿液中MMP-2、MMP-9及MMP-9/NGAL复合物的表达在乳腺癌筛查中的意义[J].首都医科大学学报,2008,29(3):395-398. 被引量:4
  • 2丁峰,张秋实,邢福祺.MMP-2/TIMP-2在妊娠滋养细胞疾病组织中的表达及意义[J].南方医科大学学报,2007,27(2):150-152. 被引量:5
  • 3杨培峰,李金科,熊庆.同型半胱氨酸对滋养细胞基质金属蛋白酶2、9表达的影响[J].中华妇产科杂志,2007,42(3):184-186. 被引量:2
  • 4Tsai CH,Lin FM,Yang YC,et al.Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice[J].Clin Cancer Res,2009,15(17):5435-5444.
  • 5Noh HJ,Sung EG,Kim JY,et al.Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by apigenin via the inhibition of p38 mitogen-activated protein kinase-dependent matrix metalloproteinase-9 expression[J].Oncol Rep,2010,24(1):277-283.
  • 6Lindenmeyer F,Li H,Menashi S,et al.Apigenin acts on the tumor cell invasion process and regulates protease production[J].Nutr Cancer,2001,39(1):139-147.
  • 7Fang J,Zhou Q,Liu LZ,et al.Apigenin inhibits tumor angiogenesis through decreasing HIF-1alpha and VEGF expression[J].Carcinogenesis,2007,28(4):858-864.
  • 8Roomi MW,Monterrey JC,Kalinovsky T,et al.Inhibition of invasion and MMPs by a nutrient mixture in human cancer cell lines:a correlation study[J].Exp Oncol,2010,32(4):243-248.
  • 9Zhang M,Zhu GY,Gao HY,et al.Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric adenocarcinoma[J].J Surg Oncol,2011,103(3):243-247.
  • 10Anne Juuti, Johan Lundin. Epithelial MMP -2 expression correlates with worse prognosis in pancreatic cancer[ J]. Oncology, 2006,71 : 61 - 68.

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部